U.S. Telecom Services and Carriers Stock News

BofA Securities’ upgrade of SPX Technologies (SPXC) has put fresh attention on the stock. This comes alongside completed and planned HVAC acquisitions, as well as an emphasis on organic capacity additions, new products, and capital deployment. See our latest analysis for SPX Technologies. The recent upgrade and HVAC deals come on top of strong momentum, with a 1 day share price return of 3.5%, a 30 day share price return of 9.81%, and a 1 year total shareholder return of 60.41%. This points...

Elanco Animal Health has announced that founding Chairman R. David Hoover and Dr. Deborah Kochevar will not stand for re-election at the May 2026 Annual Meeting, reducing the Board to nine directors and marking an important leadership transition following the company’s separation from Eli Lilly. With Hoover’s IPO-era governance experience and Kochevar’s oversight of the Innovation, Science, and Technology committee both stepping away, investors may focus more closely on how new and remaining...

Hess Midstream LP has released its fourth-quarter 2025 results, reporting revenue of US$404.2 million and net income of US$93.3 million, both higher than the same period a year earlier, with basic and diluted earnings per share from continuing operations at US$0.72 versus US$0.68 previously. The combination of rising revenue and a sharper increase in net income suggests improved cost efficiency or a more profitable service mix within Hess Midstream’s fee-based midstream operations. We’ll now...

Energizer Holdings (ENR) is back in focus after first quarter results showed sales of US$778.9 million alongside a net loss of US$3.4 million, while management reaffirmed 2026 guidance despite margin pressure from tariffs and softer consumer demand. See our latest analysis for Energizer Holdings. That backdrop helps explain why the 1 month share price return of 10.11% and year to date share price return of 14.25% sit alongside a 1 year total shareholder return of 22.73% and 5 year total...

Event context and recent performance snapshot Distribution Solutions Group (DSGR) did not have a single headline event driving attention today. However, recent returns and fundamentals give you a few concrete data points to work with. The stock closed at US$30.84, with a roughly flat move over the past week and a small gain over the past month. Over the past 3 months, the share price shows a stronger positive return, while the total return over the past year is more muted compared with its 3...

Laureate Education recently raised its full-year revenue guidance to as much as US$1.69 billion and expanded its share repurchase authorization by US$150 million, supported by 9% third-quarter revenue growth and a 7% increase in new enrollments year to date, while ending September with US$138.60 million in net cash. This combination of upgraded outlook, reinforced buybacks, and a cash-rich balance sheet underscores management’s focus on measured expansion and returning capital to...

Erie Indemnity recently saw its shares come under pressure as investors reacted to weaker sentiment around the company’s latest financial results and the broader market backdrop. The stock’s slide to a new 52-week low, alongside higher-than-usual trading volume, points to heightened anxiety ahead the February earnings update that has now passed. We will now examine how rising investor concern over recent financial results shapes Erie Indemnity’s investment narrative going forward. Capitalize...

Vulcan Materials’ board has raised its quarterly cash dividend by 6% to US$0.52 per share, payable on March 23, 2026, to shareholders of record on March 9, following its long-running pattern of dividend increases. This latest hike, marking the ninth consecutive annual dividend increase, underscores management’s confidence in cash generation and commitment to returning capital to shareholders ahead of the upcoming earnings release. Next, we’ll examine how this ninth straight dividend increase...

MannKind (NasdaqGM:MNKD) has started enrolling pediatric patients in its pivotal INHALE-1ST trial of Afrezza inhaled insulin. The study focuses on using Afrezza shortly after a type 1 diabetes diagnosis in children and adolescents. The FDA is currently reviewing a supplemental application to expand Afrezza’s label to pediatric use, with a decision expected in the coming months. If cleared, Afrezza could become the first needle free insulin option for young patients in the US. Shares of...

monday.com (NasdaqGS:MNDY) reported strong fourth quarter results, underscoring solid current business performance. The company issued a cautious revenue outlook for 2026, pointing to AI driven competitive pressures and softer demand from small businesses. Management indicated it will no longer emphasize long term revenue targets, signaling a shift in how it is framing future growth. monday.com, listed on NasdaqGS:MNDY, provides work management and collaboration tools used by teams across a...

NNN REIT (NYSE:NNN) reported a 36th consecutive year of dividend increases in 2025. The company recorded its highest ever annual acquisition volume, with more than $900m invested in new properties. NNN REIT highlighted a portfolio with high occupancy and long lease terms alongside this expansion. NNN REIT enters 2026 with a long dividend growth streak that sets it apart from many other U.S. listed companies. Its shares recently traded at $44.34, with the stock up 3.3% over the past week,...

What JBS stock’s recent move might be telling you JBS (NYSE:JBS) has attracted fresh attention after a recent share price move, with the stock up about 1.1% over the past week and roughly 9.1% over the past month. See our latest analysis for JBS. The recent 30 day share price return of 9.1% and 90 day return of 15.4% suggest building momentum for JBS, with the current share price at $16.0 anchoring those shorter term moves. If this has you thinking about where else momentum could be forming,...

Unity Software (NYSE:U) is reshaping its Board of Directors, with Bernard Kim set to join as an independent director. Longtime directors including founder David Helgason and Tomer Bar Zeev are retiring from the board, with Mary Schmidt Campbell also scheduled to step down. These changes mark a material shift in Unity's board composition and corporate oversight. Unity runs a widely used real time 3D engine and toolset that powers many mobile and console games, as well as applications in...

Progressive (PGR) is back in focus after several major banks reaffirmed positive views following strong December and quarterly results, as rising net premiums and solid profitability metrics draw fresh attention from insurance sector investors. See our latest analysis for Progressive. At a share price of $204.53, Progressive’s 1-day share price return of a 0.45% decline and 90-day share price return of a 9.24% decline compare with a 5-year total shareholder return of 162.88%. This indicates...

Carlyle Group (CG) is back in focus after reporting fourth quarter results that topped Wall Street expectations on both revenue and non GAAP earnings per share, prompting a broadly positive reaction from analysts. See our latest analysis for Carlyle Group. Carlyle’s recent earnings beat, dividend affirmation and ongoing share buybacks come against a share price that has pulled back, with a 30 day share price return of 16.96% and a year to date share price decline of 10.47%, even as the 1 year...

In recent days, GATX’s business update highlighted slower-than-hoped adoption of its railcar solutions, rising cash burn, and a tight liquidity position that could require fresh equity financing. At the same time, the company has attracted strong institutional interest and AI-driven trading support, with market participants emphasizing operational momentum and long-term leasing fundamentals despite these financial pressures. We’ll now examine how this mix of robust institutional support and...

Why Bio-Techne Is Back on Investor Radar Bio-Techne (TECH) has drawn fresh attention after quarterly results topped Wall Street expectations, supported by large pharmaceutical customers, tighter cost control and new product momentum in 3D stem cell and organoid research tools. See our latest analysis for Bio-Techne. Those earnings and product updates have landed against a mixed share price backdrop, with a 12.73% 1 month share price decline and an 8.58% 1 year total shareholder return...

WEX (WEX) has just wrapped up FY 2025 with Q4 revenue of US$672.9 million and basic EPS of US$2.45, while full year trailing twelve month revenue came in at about US$2.7 billion and EPS at US$8.57. Over recent quarters the company has seen revenue move from US$636.5 million in Q4 2024 to US$672.9 million in Q4 2025, with basic EPS shifting from US$1.62 to US$2.45 over the same period, giving investors a clear view of how the top and bottom lines have tracked into this latest print. With a...

If you are wondering whether Hanover Insurance Group's share price still reflects its underlying worth, this article walks through the key numbers that matter before you commit fresh capital. The stock closed at US$171.80, with returns of 1.1% over 30 days, 7.8% over 1 year, 29.3% over 3 years and 70.4% over 5 years. This recent price history gives useful context for judging current value and risk. Recent coverage has focused on Hanover Insurance Group's position in the US insurance sector...

For investors wondering whether Encompass Health at around US$110 a share still offers value, or if the easy money has already been made, this article explains what the current price reflects. The stock has returned 4.5% over the last 7 days, 9.6% over 30 days, 3.5% year to date, 9.9% over 1 year, 79.3% over 3 years and 81.5% over 5 years. These figures naturally raise questions about what is now priced in. Recent attention on Encompass Health has focused on its position within US healthcare...

Pulmovant, a Roivant Sciences company, has completed patient enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. Enrollment finished ahead of schedule, marking a key clinical milestone for this potential first in class inhaled therapy. For investors watching Roivant Sciences (NasdaqGS:ROIV), this clinical update adds fresh context to a stock that has seen a very large 1 year return and a 20.6% gain year to date. Shares...

In early February 2026, Fortive Corporation reported fourth-quarter 2025 sales of US$1,122.5 million with continuing operations EPS edging higher year on year, even as full-year net income fell to US$579.2 million on modestly higher sales of US$4,159.1 million. Alongside these results, Fortive completed a multi-year buyback program totaling 43,483,303 shares for US$2,734.24 million, while management highlighted expanding recurring revenue and strong demand in its Fluke and international...

Why Sysco’s new $1.25b in senior notes matters for stock watchers Sysco (SYY) has just issued $1.25b of new senior notes, mainly to refinance commercial paper and support general corporate uses. This gives stock investors fresh information about its capital structure and debt profile. See our latest analysis for Sysco. The new senior notes come as Sysco’s share price has gained 14.9% over the past month and 20.5% over the last 90 days, with a 1 year total shareholder return of 30.9%. This...

Investors may be wondering whether Enpro is still fairly priced after a strong run, or if the current level is starting to look stretched for new money going in. The stock last closed at US$272.63, with returns of 1.9% over 7 days, 12.0% over 30 days, 24.4% year to date, 42.2% over 1 year, 133.4% over 3 years and 265.3% over 5 years. This naturally raises questions about what is already reflected in the price. Recent coverage of Enpro has focused on its position in the capital goods space...